GOLDSTEIN DOV A MD
Insider CIK 1120478 · NBSE Director · ADMA Director, 10% owner · ESPR Director · CEMP Director · DRTX Director, 10% owner · LOXO CFO and Treasurer, Director, 10% owner · BIOA Chief Financial Officer · GANX Director · COYA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GANX Gain Therapeutics, Inc. | A Award deriv | 2026-07-15 | 2026-07-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BIOA BioAge Labs, Inc. | M Exercise deriv | 2026-04-23 | 2026-04-24 | 3,542 | — | $0 | 155,833 | SEC↗ |
| BIOA BioAge Labs, Inc. | M Exercise | 2026-04-23 | 2026-04-24 | 3,542 | $4.38 | $15.5K | 36,575 | SEC↗ |
| BIOA BioAge Labs, Inc. | M Exercise deriv | 2026-03-01 | 2026-03-03 | 3,542 | — | $0 | 159,375 | SEC↗ |
| BIOA BioAge Labs, Inc. | M Exercise | 2026-03-01 | 2026-03-03 | 3,542 | $4.38 | $15.5K | 33,033 | SEC↗ |
| BIOA BioAge Labs, Inc. | A Award deriv | 2026-02-17 | 2026-02-19 | 110,000 | — | $0 | 110,000 | SEC↗ |
| BIOA BioAge Labs, Inc. | M Exercise deriv | 2026-02-01 | 2026-02-03 | 3,541 | — | $0 | 162,917 | SEC↗ |
| BIOA BioAge Labs, Inc. | M Exercise | 2026-02-01 | 2026-02-03 | 3,541 | $4.38 | $15.5K | 29,491 | SEC↗ |
| BIOA BioAge Labs, Inc. | M Exercise deriv | 2026-01-16 | 2026-01-21 | 3,542 | — | $0 | 166,458 | SEC↗ |
| BIOA BioAge Labs, Inc. | M Exercise | 2026-01-16 | 2026-01-21 | 3,542 | $4.38 | $15.5K | 25,950 | SEC↗ |
| BIOA BioAge Labs, Inc. | M Exercise deriv | 2026-01-13 | 2026-01-15 | 27,000 | — | $0 | 92,587 | SEC↗ |
| BIOA BioAge Labs, Inc. | M Exercise | 2026-01-13 | 2026-01-15 | 27,000 | $8.39 | $226.5K | 49,408 | SEC↗ |
| BIOA BioAge Labs, Inc. | S Sale | 2026-01-13 | 2026-01-15 | 8,974 | $18.43 | $165.4K | 40,434 | SEC↗ |
| BIOA BioAge Labs, Inc. | S Sale | 2026-01-13 | 2026-01-15 | 1,923 | $21.08 | $40.5K | 22,408 | SEC↗ |
| BIOA BioAge Labs, Inc. | S Sale | 2026-01-13 | 2026-01-15 | 11,663 | $20.54 | $239.6K | 24,331 | SEC↗ |
| BIOA BioAge Labs, Inc. | S Sale | 2026-01-13 | 2026-01-15 | 4,440 | $19.45 | $86.4K | 35,994 | SEC↗ |
| COYA Coya Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| COYA Coya Therapeutics, Inc. | M Exercise deriv | 2025-08-18 | 2025-08-19 | 17,557 | — | $0 | 0 | SEC↗ |
| COYA Coya Therapeutics, Inc. | M Exercise | 2025-08-18 | 2025-08-19 | 17,557 | $1.09 | $19.1K | 27,557 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2025-06-24 | 2025-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| COYA Coya Therapeutics, Inc. | A Award deriv | 2025-02-25 | 2025-02-25 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BIOA BioAge Labs, Inc. | A Award deriv | 2025-02-18 | 2025-02-20 | 170,000 | — | $0 | 170,000 | SEC↗ |
| COYA Coya Therapeutics, Inc. | A Award deriv | 2025-01-01 | 2025-01-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2024-06-24 | 2024-06-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| COYA Coya Therapeutics, Inc. | A Award deriv | 2024-01-01 | 2024-01-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2023-06-23 | 2023-06-26 | 10,500 | — | $0 | 10,500 | SEC↗ |
| COYA Coya Therapeutics, Inc. | P Buy deriv | 2023-01-03 | 2023-01-04 | 5,000 | — | $0 | 5,000 | SEC↗ |
| COYA Coya Therapeutics, Inc. | P Buy | 2023-01-03 | 2023-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2022-09-20 | 2022-09-22 | 10,500 | — | $0 | 10,500 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | A Award deriv | 2022-09-09 | 2022-09-12 | 37,600 | — | $0 | 37,600 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | A Award deriv | 2021-08-19 | 2021-09-17 | 38,135 | — | $0 | 38,135 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | P Buy | 2021-06-18 | 2021-06-21 | 8,000 | $4.75 | $38.0K | 30,000 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | P Buy | 2021-04-26 | 2021-04-27 | 12,000 | $5.00 | $60.0K | 22,000 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | A Award deriv | 2020-09-09 | 2020-09-11 | 14,634 | — | $0 | 14,634 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | P Buy | 2020-04-30 | 2020-05-04 | 10,000 | $6.00 | $60.0K | 10,000 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award | 2020-02-28 | 2020-05-01 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award deriv | 2020-02-28 | 2020-03-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award | 2020-02-28 | 2020-03-03 | 7,500 | — | $0 | 7,500 | SEC↗ |
| NBSE NeuBase Therapeutics, Inc. | A Award deriv | 2019-07-12 | 2019-07-16 | 227,330 | — | $0 | 227,330 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award deriv | 2019-03-13 | 2019-03-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award deriv | 2018-06-22 | 2018-06-25 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise deriv | 2018-06-06 | 2018-06-08 | 5,000 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise deriv | 2018-06-06 | 2018-06-08 | 8,000 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other | 2018-06-06 | 2018-06-08 | 8,000 | — | $0 | 47 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other | 2018-06-06 | 2018-06-08 | 5,000 | — | $0 | 8,047 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise | 2018-06-06 | 2018-06-08 | 5,000 | $14.42 | $72.1K | 5,047 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise | 2018-06-06 | 2018-06-08 | 8,000 | $17.75 | $142.0K | 13,047 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2018-05-23 | 2018-05-25 | 10,100 | — | $0 | 10,100 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise deriv | 2017-12-18 | 2017-12-20 | 21,471 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other | 2017-12-18 | 2017-12-20 | 21,471 | — | $0 | 47 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise | 2017-12-18 | 2017-12-20 | 21,471 | $3.70 | $79.4K | 21,518 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other | 2017-12-05 | 2017-12-08 | 38 | — | $0 | 47 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award deriv | 2017-06-06 | 2017-06-08 | 53,837 | — | $0 | 53,837 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2017-04-17 | 2017-04-19 | 14,000 | — | $0 | 14,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2017-03-22 | 2017-03-23 | 312,642 | $38.82 | $12.14M | 837,125 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2017-03-21 | 2017-03-23 | 487,358 | $43.48 | $21.19M | 1,149,767 | SEC↗ |
| CEMP CEMPRA, INC. | S Sale | 2017-03-08 | 2017-03-09 | 99,900 | $3.57 | $356.6K | 0 | SEC↗ |
| CEMP CEMPRA, INC. | S Sale | 2017-03-07 | 2017-03-09 | 50,100 | $3.53 | $176.9K | 99,900 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award deriv | 2017-02-14 | 2017-02-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CEMP CEMPRA, INC. | S Sale | 2017-01-13 | 2017-01-18 | 105,460 | $3.40 | $358.6K | 150,000 | SEC↗ |
| CEMP CEMPRA, INC. | S Sale | 2017-01-06 | 2017-01-06 | 437,600 | $3.64 | $1.59M | 255,460 | SEC↗ |
| CEMP CEMPRA, INC. | S Sale | 2017-01-05 | 2017-01-06 | 500,000 | $3.20 | $1.60M | 693,060 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2017-01-03 | 2017-02-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2016-06-09 | 2016-06-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CEMP CEMPRA, INC. | J Other | 2016-03-07 | 2016-03-09 | 999,955 | — | $0 | 1,193,060 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award deriv | 2016-01-28 | 2016-02-01 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CEMP CEMPRA, INC. | S Sale | 2016-01-04 | 2016-01-06 | 842 | $30.06 | $25.3K | 50 | SEC↗ |
| CEMP CEMPRA, INC. | M Exercise | 2016-01-04 | 2016-01-06 | 842 | — | $0 | 892 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2016-01-01 | 2016-01-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CEMP CEMPRA, INC. | M Exercise deriv | 2015-06-22 | 2016-01-06 | 842 | — | $0 | 9,158 | SEC↗ |
| CEMP CEMPRA, INC. | M Exercise deriv | 2015-06-22 | 2015-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| CEMP CEMPRA, INC. | M Exercise deriv | 2015-06-22 | 2015-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| CEMP CEMPRA, INC. | M Exercise deriv | 2015-06-22 | 2015-06-24 | 5,000 | — | $0 | 10,000 | SEC↗ |
| CEMP CEMPRA, INC. | M Exercise deriv | 2015-06-22 | 2015-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| CEMP CEMPRA, INC. | S Sale | 2015-06-22 | 2015-06-24 | 50,000 | $35.74 | $1.79M | 50 | SEC↗ |
| CEMP CEMPRA, INC. | M Exercise | 2015-06-22 | 2015-06-24 | 15,000 | — | $0 | 35,050 | SEC↗ |
| CEMP CEMPRA, INC. | M Exercise | 2015-06-22 | 2015-06-24 | 15,000 | — | $0 | 20,050 | SEC↗ |
| CEMP CEMPRA, INC. | M Exercise | 2015-06-22 | 2015-06-24 | 5,000 | — | $0 | 5,050 | SEC↗ |
| CEMP CEMPRA, INC. | M Exercise | 2015-06-22 | 2015-06-24 | 15,000 | — | $0 | 50,050 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2015-05-14 | 2015-05-18 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CEMP CEMPRA, INC. | J Other | 2015-05-14 | 2015-05-18 | 1,099,950 | — | $0 | 2,193,110 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other | 2015-04-28 | 2015-04-30 | 199,991 | — | $0 | 1,637,125 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2015-04-24 | 2015-04-27 | 61,726 | $106.10 | $6.55M | 1,837,125 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2015-04-24 | 2015-04-27 | 5,743 | $108.00 | $620.2K | 1,898,851 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2015-04-23 | 2015-04-27 | 150,000 | $109.10 | $16.36M | 1,904,594 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise deriv | 2015-04-02 | 2015-04-03 | 3,159 | — | $0 | 41,074 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise deriv | 2015-04-02 | 2015-04-03 | 846 | — | $0 | 22,005 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise | 2015-04-02 | 2015-04-03 | 846 | $3.65 | $3.1K | 62,714 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise | 2015-04-02 | 2015-04-03 | 3,159 | $7.14 | $22.6K | 65,873 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise deriv | 2015-04-01 | 2015-04-03 | 31,595 | — | $0 | 44,233 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise deriv | 2015-04-01 | 2015-04-03 | 7,617 | — | $0 | 22,851 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise | 2015-04-01 | 2015-04-03 | 31,595 | $7.14 | $225.6K | 61,868 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise | 2015-04-01 | 2015-04-03 | 7,617 | $3.65 | $27.8K | 30,273 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award deriv | 2015-01-30 | 2015-02-03 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2015-01-01 | 2015-01-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion deriv | 2014-08-06 | 2014-08-06 | 506,960 | — | $0 | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion deriv | 2014-08-06 | 2014-08-06 | 2,343,749 | — | $0 | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion deriv | 2014-08-06 | 2014-08-06 | 506,960 | — | $0 | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion deriv | 2014-08-06 | 2014-08-06 | 2,343,749 | — | $0 | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion | 2014-08-06 | 2014-08-06 | 2,850,709 | — | $0 | 3,039,416 | SEC↗ |
| LOXO Loxo Oncology, Inc. | P Buy | 2014-08-06 | 2014-08-06 | 413,077 | $13.00 | $5.37M | 3,452,493 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion | 2014-08-06 | 2014-08-06 | 2,850,709 | — | $0 | 3,039,416 | SEC↗ |
| LOXO Loxo Oncology, Inc. | P Buy | 2014-08-06 | 2014-08-06 | 413,077 | $13.00 | $5.37M | 3,452,493 | SEC↗ |
| ADMA ADMA BIOLOGICS, INC. | A Award deriv | 2014-06-19 | 2014-06-23 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2014-05-15 | 2014-05-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2014-01-08 | 2014-01-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-01 | 71,237 | — | $0 | 71,237 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-01 | 497,666 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion deriv | 2013-07-01 | 2013-07-01 | 1,816,475 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion | 2013-07-01 | 2013-07-01 | 1,816,475 | — | $0 | 1,816,475 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2013-07-01 | 2013-07-01 | 238,119 | $14.00 | $3.33M | 2,054,594 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2013-02-04 | 2013-02-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | C Conversion deriv | 2012-07-24 | 2012-07-25 | 16,157,707 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | P Buy | 2012-07-24 | 2012-07-25 | 1,111,111 | $9.00 | $10.00M | 3,130,824 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | C Conversion | 2012-07-24 | 2012-07-25 | 2,019,713 | — | $0 | 2,019,713 | SEC↗ |
| NONE ADMA BIOLOGICS, INC. | A Award deriv | 2012-04-04 | 2012-04-05 | 13,258 | — | $0 | 13,258 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2012-03-20 | 2012-03-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NONE R&R ACQUISITION VI, INC | A Award | 2012-02-13 | 2012-02-15 | 2,516,855 | — | $0 | 2,516,855 | SEC↗ |
| CEMP CEMPRA, INC. | P Buy | 2012-02-07 | 2012-02-09 | 1,213,663 | $6.00 | $7.28M | 3,293,060 | SEC↗ |